Prevalence, Risk Factors and Molecular Epidemiology of Carbapenem-Resistant Klebsiella Pneumoniae in Patients from Zhejiang, China, 2008–2018

Yanyan Hu,Congcong Liu,Zhangqi Shen,Hongwei Zhou,Junmin Cao,Shi Chen,Huoyang Lv,Mingming Zhou,Qiang Wang,Long Sun,Qiaoling Sun,Fupin Hu,Yang Wang,Rong Zhang

DOI: https://doi.org/10.1080/22221751.2020.1799721

2020-01-01

Emerging Microbes & Infections

Abstract:ABSTRACTCarbapenem-resistant Klebsiella pneumoniae (CRKP) is emerging as a worldwide public health concern; however, the long-term molecular epidemiological surveillance of clinical CRKP in China is limited. We conducted a retrospective observational study (2008–2018) to assess the prevalence, susceptibility, risk factors and molecular epidemiology of clinical CRKP isolates. We found the prevalence of CRKP increased from 2.5%, 2008 to 15.8%, 2018. CRKP were significantly more frequent among hospitalized patients from ICU, and it was significantly more likely to be isolated from the capital city (Hangzhou) and the patients aged ≥60 years. Additionally, seasons and specimen types were associated with CRKP infections. The main CRKP sequence type (ST) was ST11, and blaKPC-2 was the most prevalent gene variant. Together these data reveal an increasing incidence and resistance trends among CRKP, especially the ST11-blaKPC-2-CRKP, in Zhejiang, during 2008–2018. Our findings are important for hospitals to limit its dissemination and optimize antibiotic administration.